These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9038617)

  • 1. Cisplatin combined with the new cisplatin-procaine complex DPR: in vitro and in vivo studies.
    Viale M; Vannozzi MO; Merlo F; Cafaggi S; Parodi B; Esposito M
    Eur J Cancer; 1996 Dec; 32A(13):2327-33. PubMed ID: 9038617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
    Viale M; Cafaggi S; Parodi B; Esposito M
    Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of a new cis-diammineplatinum (II) complex containing procaine hydrochloride.
    Cafaggi S; Esposito M; Parodi B; Vannozzi MO; Viale M; Pellecchia C; Fulco RA; Merlo F; Zicca A; Cadoni A
    Anticancer Res; 1992; 12(6B):2285-92. PubMed ID: 1295476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of cisplatin-procaine complex DPR with anticancer drugs increases cytotoxicity against ovarian cancer cell lines.
    Viale M; Pastrone I; Pellecchia C; Vannozzi MO; Cafaggi S; Esposito M
    Anticancer Drugs; 1998 Jun; 9(5):457-63. PubMed ID: 9660544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved therapeutic index of cisplatin by procaine hydrochloride.
    Esposito M; Fulco RA; Collecchi P; Zicca A; Cadoni A; Merlo F; Rosso R; Sobrero A
    J Natl Cancer Inst; 1990 Apr; 82(8):677-84. PubMed ID: 2319610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modifications of cell-cycle induced by dpr, a new platinum-triamine complex containing procaine.
    Viale M; Melioli G; Pasquetti W; Meta M; Cafaggi S; Esposito N
    Int J Oncol; 1994 May; 4(5):1047-51. PubMed ID: 21567018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the cisplatin-procaine complex DPR in combination with several anticancer agents on murine P388 leukemic cells in vitro and in vivo.
    Pastrone I; Viale M; Cafaggi S; Mariggiò MA; Parodi A; Esposito M
    Invest New Drugs; 1998-1999; 16(4):297-302. PubMed ID: 10426661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transplacental passage of Pt after treatment with the new triamine complex cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N4]-chloride platinum (II) monohydrochloride monohydrate.
    Ognio E; Chiavarina B; Caviglioli G; Lapide M; Viale M
    Arch Toxicol; 2004 Oct; 78(10):584-8. PubMed ID: 15150682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).
    Grossie VB; Valdivieso M; Drewinko B; Loo TL
    Cancer Chemother Pharmacol; 1984; 13(1):27-30. PubMed ID: 6539657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD; O'Dwyer PJ; Trader MW
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL; Roberts BJ; Howard CT; Leopold WR
    Cancer Res; 1994 Aug; 54(16):4412-8. PubMed ID: 8044790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cell growth, induction of apoptosis and mechanism of action of the novel platinum compound cis-diaminechloro-[2-(diethylamino) ethyl 4-amino-benzoate, N(4)]-chloride platinum (II) monohydrochloride monohydrate.
    Mariggiò MA; Cafaggi S; Ottone M; Parodi B; Vannozzi MO; Mandys V; Viale M
    Invest New Drugs; 2004 Jan; 22(1):3-16. PubMed ID: 14707490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical in vitro evaluation of hematotoxicity of the cisplatin-procaine complex DPR.
    Viale M; Minetti S; Ottone M; Lerza R; Parodi B; Pannacciulli I
    Anticancer Drugs; 2003 Feb; 14(2):163-6. PubMed ID: 12569303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline.
    Coluccia M; Sava G; Loseto F; Nassi A; Boccarelli A; Giordano D; Alessio E; Mestroni G
    Eur J Cancer; 1993; 29A(13):1873-9. PubMed ID: 8260245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Para-aminobenzoic acid suppression of cis-diamminedichloroplatinum(II) nephrotoxicity.
    Esposito M; Vannozzi MO; Viale M; Fulco RA; Collecchi P; Merlo F; De Cian F; Zicca A; Cadoni A; Poirier MC
    Carcinogenesis; 1993 Dec; 14(12):2595-9. PubMed ID: 8269632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy of early and advanced murine P388 leukaemia with bouvardin, cis-diamminedichloroplatinum and vincristine.
    Adwankar MK; Khandalekar DD; Chitnis MP
    Oncology; 1984; 41(5):370-3. PubMed ID: 6540853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.
    Berners-Price SJ; Mirabelli CK; Johnson RK; Mattern MR; McCabe FL; Faucette LF; Sung CM; Mong SM; Sadler PJ; Crooke ST
    Cancer Res; 1986 Nov; 46(11):5486-93. PubMed ID: 3756897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of drug sequence in therapeutic selectivity of the combination of 5-fluorouracil and cis-platin.
    Palmeri S; Trave F; Russello O; Rustum YM
    Sel Cancer Ther; 1989; 5(4):169-77. PubMed ID: 2623382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
    Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.